2-Amino-6-chloro-2'-O-propargylpurine-9-riboside CAS 2095417-35-7

Introduction：Basic information about 2-Amino-6-chloro-2'-O-propargylpurine-9-riboside CAS 2095417-35-7, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.

2-Amino-6-chloro-2'-O-propargylpurine-9-riboside Basic information

• Product Name: 2-Amino-6-chloro-2'-O-propargylpurine-9-riboside
• Synonyms: 2-Amino-6-chloro-2'-O-propargylpurine-9-riboside;2-Amino-6-chloropurine-9-(2’-O-propargyl)riboside;2-Amino-6-chloro-9-(2'-O-propargyl-b-D-ribofuranosyl)purine;2-Amino -6-chloropurine-9-(2’-O-pro pargyl) riboside;2-Amino-6-chloro-9-(2-O-propargyl-β-D-ribofuranosyl)-9H-purine
• CAS: 2095417-35-7
• MF: C13H14ClN5O4
• MW: 339.73
• Mol File: 2095417-35-7.mol

2-Amino-6-chloro-2'-O-propargylpurine-9-riboside Chemical Properties

• InChI: InChI=1/C13H14ClN5O5/c1-2-3-22-9-8(21)6(20)4-23-12(9)24-19-5-16-7-10(14)17-13(15)18-11(7)19/h1,5-6,8-9,12,20-21H,3-4H2,(H2,15,17,18)/t6-,8-,9-,12?/s3
• InChIKey: QYKKSMWYIBCIBN-SFKBCKQCNA-N
• SMILES: N1C2=C(N=C(N)N=C2Cl)N(OC2OC[C@@H](O)[C@@H](O)[C@H]2OCC#C)C=1 |&1:14,16,18,r|

2-Amino-6-chloro-2'-O-propargylpurine-9-riboside Usage And Synthesis

Description

2-Amino-6-chloro-2'-O-propargylpurine-9-riboside is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc. It is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.

Uses

2-Amino-6-chloropurine-9-(2’-O-propargyl)riboside is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. 2-Amino-6-chloropurine-9-(2’-O-propargyl)riboside is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.

References

[1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005